David Roman
Stock Analyst at Goldman Sachs
(3.65)
# 2,140
Out of 4,988 analysts
244
Total ratings
52.5%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Rated: Hold | $17 → $21 | $22.80 | -7.89% | 20 | Jul 15, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $17 → $19 | $21.89 | -13.20% | 7 | Jul 15, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $19 → $21 | $16.85 | +24.63% | 4 | Jul 14, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $71 → $57 | $43.34 | +31.52% | 11 | Jul 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $31 | $10.54 | +194.12% | 2 | Jul 14, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $21 → $16 | $16.87 | -5.16% | 7 | Jul 14, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $95 → $98 | $88.26 | +11.04% | 18 | Jun 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $393.33 | +41.87% | 21 | Jun 15, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $26 → $25 | $20.43 | +22.37% | 7 | Jun 10, 2026 | |
| MDT Medtronic | Reiterated: Hold | $84 → $83 | $92.13 | -9.91% | 12 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $24 | $21.79 | +10.14% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $113 | $102.61 | +10.13% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $89 → $88 | $95.14 | -7.50% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $73 → $61 | $55.29 | +10.33% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 → $205 | $140.60 | +45.80% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $8 | $6.30 | +26.98% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $163.81 | -6.60% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $26.11 | -8.08% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $89.35 | -10.46% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $18.16 | +10.13% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $72 | $78.01 | -7.70% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $50 | $31.64 | +58.03% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $15.58 | +2.70% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $54 → $66 | $88.84 | -25.71% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $357 → $361 | $275.12 | +31.22% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $64.13 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $147 | $109.33 | +34.46% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $180.94 | -7.70% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $24.43 | -30.41% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $93 → $88 | $95.36 | -7.72% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $74.08 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $108.40 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $103 | $97.86 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $44 → $15 | $10.54 | n/a | 2 | Aug 30, 2012 |
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $22.80
Upside: -7.89%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $21.89
Upside: -13.20%
Bausch + Lomb
Jul 14, 2026
Reiterated: Hold
Price Target: $19 → $21
Current: $16.85
Upside: +24.63%
Boston Scientific
Jul 14, 2026
Reiterated: Buy
Price Target: $71 → $57
Current: $43.34
Upside: +31.52%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $10.54
Upside: +194.12%
Tandem Diabetes Care
Jul 14, 2026
Reiterated: Hold
Price Target: $21 → $16
Current: $16.87
Upside: -5.16%
Edwards Lifesciences
Jun 15, 2026
Reiterated: Buy
Price Target: $95 → $98
Current: $88.26
Upside: +11.04%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $393.33
Upside: +41.87%
Omada Health
Jun 10, 2026
Reiterated: Buy
Price Target: $26 → $25
Current: $20.43
Upside: +22.37%
Medtronic
Jun 4, 2026
Reiterated: Hold
Price Target: $84 → $83
Current: $92.13
Upside: -9.91%
Jun 3, 2026
Reiterated: Buy
Price Target: $14 → $24
Current: $21.79
Upside: +10.14%
May 31, 2026
Reiterated: Buy
Price Target: $121 → $113
Current: $102.61
Upside: +10.13%
May 29, 2026
Reiterated: Sell
Price Target: $89 → $88
Current: $95.14
Upside: -7.50%
May 27, 2026
Reiterated: Sell
Price Target: $73 → $61
Current: $55.29
Upside: +10.33%
May 27, 2026
Reiterated: Buy
Price Target: $237 → $205
Current: $140.60
Upside: +45.80%
May 27, 2026
Reiterated: Buy
Price Target: $7 → $8
Current: $6.30
Upside: +26.98%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $163.81
Upside: -6.60%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $26.11
Upside: -8.08%
May 15, 2026
Reiterated: Buy
Price Target: $80
Current: $89.35
Upside: -10.46%
May 13, 2026
Reiterated: Buy
Price Target: $20
Current: $18.16
Upside: +10.13%
May 6, 2026
Reiterated: Hold
Price Target: $73 → $72
Current: $78.01
Upside: -7.70%
May 6, 2026
Reiterated: Buy
Price Target: $54 → $50
Current: $31.64
Upside: +58.03%
May 5, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $15.58
Upside: +2.70%
May 5, 2026
Reiterated: Sell
Price Target: $54 → $66
Current: $88.84
Upside: -25.71%
May 1, 2026
Reiterated: Hold
Price Target: $357 → $361
Current: $275.12
Upside: +31.22%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $64.13
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: $147
Current: $109.33
Upside: +34.46%
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $180.94
Upside: -7.70%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $24.43
Upside: -30.41%
Feb 10, 2026
Reiterated: Sell
Price Target: $93 → $88
Current: $95.36
Upside: -7.72%
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $74.08
Upside: n/a
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $108.40
Upside: n/a
Nov 15, 2013
Reiterated: Sell
Price Target: $103
Current: $97.86
Upside: n/a
Aug 30, 2012
Reiterated: Hold
Price Target: $44 → $15
Current: $10.54
Upside: n/a